Generated: May 30, 2017
|Title:||Duloxetine enteric pellets|
|Abstract:||A superior enteric formulation of the antidepressant drug, duloxetine, is in the form of enteric pellets of which the enteric layer comprises hydroxypropylmethylcellulose acetate succinate.|
|Inventor(s):||Anderson; Neil R. (West Lafayette, IN), Oren; Peter L. (Fishers, IN), Ogura; Toshihiro (Osaka, JP), Fujii; Toshiro (Hyogo, JP)|
|Assignee:||Eli Lilly and Company (Indianapolis, IN) Shionogi & Co. (Osaka, JP)|
Patent Claim Types:|
see list of patent claims
|Composition; Compound; Process; Device;|
|Country||Document Number||Estimated Expiration||Supplementary Protection Certificate||SPC Country||SPC Expiration|
|Georgia, Republic of||P20063944||► Subscribe|
|European Patent Office||0693282||► Subscribe||PA2005001||Lithuania||► Subscribe|
| This preview shows a limited data set|
Subscribe for full access, or try a Trial
The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.
Export unavailable in trial.
Subscribe for complete access.